obesity-congress-diabetes-congress-2018-posters

Page 61

O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n

Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018

Biomedical Research

ISSN: 0976-1683

Volume 29

WORLD OBESITY CONGRESS

WORLD VACCINES AND IMMUNOLOGY CONGRESS

DIABETES AND ENDOCRINOLOGY

International Conference on

Joint Event on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

YEARS

Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-014

EFFECT OF

NIGELLA SATIVA

SEEDS ON THE GLYCEMIC CONTROL OF

PATIENTS WITH TYPE1 DIABETES MELLITUS IN NILE RIVER STATE

Omer A Musa

and

Malak E Ahmed

The National Ribat University, Sudan

igella sativa

(NS) is widely used medicinal plant throughout the world. Seeds and oil have a long history of usage in various

aspects of medicines and food. It has is used to treat a wide range of diseases including diabetes mellitus (DM). DM is a

chronic incurable disease with high mortality and morbidity and increasing prevalence. The aim of this study was to investigate

hypoglycemic effect (NS) in type 1 diabetic patients. Nine patients with type I diabetes were included in the study. They were giv-

en NS (2 gm per day) beside their regular treatment (insulin) for 30 days. At the end of the study fasting blood glucose (FBG) was

checked and data was analyzed using t-test and paired t-test in statistical package for the social sciences (SPSS) 22 software.

The mean levels of FBS before and one month after the intervention were 227±65, 128±57.6 respectively. There was significant

reduction in FBS before and after treatment (P=0.003). Results showed a significant improvement in FBG in type 1 diabetic pa-

tient used NS for 30 days. More studies are recommended in the future to determine the optimal dose, duration and frequency

of NS as an antidiabetic drug as well as to study effect of NS in prevention of diabetic complication.